Skip to content

Intraperitoneal Lidocaine and Bupivacaine for Postoperative Pain After Laparoscopic Surgery

The Effectiveness of Intraperitoneal Lidocaine and Bupivacaine Instillation for Reducing Postoperative Pain in Laparoscopic Abdominal Surgery: A Randomized Controlled Trial

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07775599
Acronym
IPLA
Enrollment
64
Registered
2026-08-20
Start date
2025-08-06
Completion date
2026-07-05
Last updated
2026-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abdominal Laparoscopic and/or Robotic Surgery, Bupivacaine, Lidocaine, Local Anasthesia, Post Operative Pain, Acute

Keywords

Abdominal Laparoscopic Surgery, local anasthesia, Pain, lidocaine, Bupivacaine

Brief summary

The goal of this clinical trial is to determine the safety and efficacy of combined intraperitoneal local anesthetic instillation and port-site infiltration using lidocaine and bupivacaine in adults aged 18 to 60 undergoing elective laparoscopic abdominal surgeries (such as laparoscopic cholecystectomy, appendectomy, or hernia repair). The main questions it aims to answer are: Does combined intraperitoneal local anesthetic instillation and port-site infiltration reduce immediate and early (up to 4 hours) postoperative pain scores? Does this intervention reduce the early need for additional postoperative analgesics and shorten the length of hospital stay? Researchers will compare the treatment group receiving lidocaine (2%) and bupivacaine (0.5%) by intraperitoneal instillation and port-site infiltration with a control group receiving normal saline by the corresponding routes to determine whether the local anesthetic intervention reduces postoperative pain and analgesic requirements. Participants will undergo scheduled elective laparoscopic abdominal surgery and receive either the local anesthetic intervention or normal saline during the surgical procedure. Pain will be assessed using the Visual Analog Scale (VAS) immediately after surgery in the recovery room and again at 2 and 4 hours after surgery. Analgesic needs will be monitored and documented, and total hospital stay will be recorded.

Interventions

DRUGLidocaine

10 mL lidocaine 2% administered intraoperatively by intraperitoneal instillation and port-site infiltration

Intraoperative intraperitoneal instillation and port-site infiltration of normal saline

DRUGBupivacaine

10 mL bupivacaine 0.5% administered intraoperatively by intraperitoneal instillation and port-site infiltration

Sponsors

Misr University for Science and Technology
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Adults aged 18 to 60 years. * Scheduled for laparoscopic abdominal surgery (e.g., laparoscopic cholecystectomy, laparoscopic appendectomy, or laparoscopic hernia repair). * American Society of Anesthesiologists (ASA) physical status I or II. * No history of chronic pain, opioid dependence, or severe medical comorbidities. * Able and willing to provide written informed consent.

Exclusion criteria

* Conversion from laparoscopic to open surgery. * Acute cholecystitis, gangrene, or empyema of the gallbladder. * Oncologic or extensive laparoscopic procedures expected to have a prolonged operative time. * Known allergy or hypersensitivity to lidocaine, bupivacaine, or other local anesthetic agents. * Diabetes mellitus. * Current systemic corticosteroid use. * Pregnancy. * Cardiac, pulmonary, hepatic, or renal disorders. * History of opioid use or opioid dependence.

Design outcomes

Primary

MeasureTime frameDescription
Need for rescue opioid analgesiaImmediately after surgery, 2 hours after surgery, and 4 hours after surgeryNumber of participants requiring rescue opioid analgesia for postoperative pain.

Secondary

MeasureTime frameDescription
Postoperative pain intensityImmediately after surgery, 2 hours after surgery, and 4 hours after surgeryPostoperative pain intensity assessed using the Visual Analog Scale (VAS), ranging from 0 to 10, with higher scores indicating greater pain intensity.
Length of hospital stayFrom admission until hospital discharge (up to 1 week)Duration of hospitalization, measured from admission to discharge.
Surgery durationDuring surgeryDuration of surgery measured in minutes from anesthesia induction until completion of wound dressing.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 21, 2026